Paul A DiSilvestro (Paul DiSilvestro)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Sentinel Lymph Node

Placebo Controlled

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Charles N Landen, Ronald J Buckanovich, Michael W Sill, Robert S Mannel, Joan L Walker, Paul A DiSilvestro, Cara A Mathews, David G Mutch, Marcia L Hernandez, Lainie P Martin, Erin Bishop, Sarah E Gill, Mary E Gordinier, Robert A Burger, Carol Aghajanian, Joyce F Liu, Kathleen M Moore, Michael A Bookman
Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (21) (2024)
Charles N Landen, Ronald J Buckanovich, Michael W Sill, Robert S Mannel, Joan L Walker, Paul A DiSilvestro, Cara A Mathews, David G Mutch, Marcia L Hernandez, Lainie P Martin, Erin Bishop, Sarah E Gill, Mary E Gordinier, Robert A Burger, Carol Aghajanian, Joyce F Liu, Kathleen M Moore, Michael A Bookman
Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Charles N Landen, Ronald J Buckanovich, Michael W Sill, Robert S Mannel, Joan L Walker, Paul A DiSilvestro, Cara A Mathews, David G Mutch, Marcia L Hernandez, Lainie P Martin, Erin Bishop, Sarah E Gill, Mary E Gordinier, Robert A Burger, Carol Aghajanian, Joyce F Liu, Kathleen M Moore, Michael A Bookman
Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (21) (2024)
Charles N Landen, Ronald J Buckanovich, Michael W Sill, Robert S Mannel, Joan L Walker, Paul A DiSilvestro, Cara A Mathews, David G Mutch, Marcia L Hernandez, Lainie P Martin, Erin Bishop, Sarah E Gill, Mary E Gordinier, Robert A Burger, Carol Aghajanian, Joyce F Liu, Kathleen M Moore, Michael A Bookman
Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Matthew A Powell, Virginia L Filiaci, Martee L Hensley, Helen Q Huang, Kathleen M Moore, Krishnansu S Tewari, Larry J Copeland, Angeles A Secord, David G Mutch, Alessandro Santin, David P Warshal, Nick M Spirtos, Paul A DiSilvestro, Olga B Ioffe, David Scott Miller
Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (9) (2022)
Paul A DiSilvestro, Susana Banerjee, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael L Friedlander, Alla Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S Sonke, Charlie Gourley, Amit M Oza, Antonio Gonzáles Martin, Carol Aghajanian, William H Bradley, Cara A Mathews, Joyce F Liu, John McNamara, Elizabeth S Lowe, Mei-Lin Ah-See, Kathleen M Moore, null null
Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Maaike H M Oonk, Brian M Slomovitz, Peter J W Baldwin, Helena C van Doorn, Jacobus van der Velden, Joanne A de Hullu, Katja N Gaarenstroom, Brigitte F M Slangen, Ignace Vergote, Mats Brännström, Eleonora B L van Dorst, Willemien J van Driel, Ralph H Hermans, David Nunns, Martin Widschwendter, David Nugent, Cathrine M Holland, Aarti Sharma, Paul A DiSilvestro, Robert Mannel, Dorry Boll, David Cibula, Al Covens, Diane Provencher, Ingo B Runnebaum, David Luesley, Patricia Ellis, Timothy J Duncan, Ming Y Tjiong, Derek J Cruickshank, Preben Kjølhede, Charles F Levenback, Jiri Bouda, Katharina E Kieser, Connie Palle, Nicola M Spirtos, David M O'Malley, Mario L Leitao, Melissa A Geller, Kalyan Dhar, Viren Asher, Karl Tamussino, Daniel H Tobias, Christer Borgfeldt, Jayanthi S Lea, Jo Bailey, Margareta Lood, Brynhildur Eyjolfsdottir, Stephen Attard-Montalto, Krishnansu S Tewari, Ranjit Manchanda, Pernille Tine Jensen, Par Persson, Linda Van Le, Hein Putter, Geertruida H de Bock, Bradley J Monk, Carien L Creutzberg, Ate G J van der Zee
Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (32) (2021)